Deals
SoftBank in Talks to Invest in India’s Online Pharmacy
- API seeking valuation of at least $5.6 billion in new round
- Pharmeasy’s parent is targeting a listing in next 12-18 months
The Pharmeasy website.
Source: Pharmeasy
This article is for subscribers only.
SoftBank Group Corp. is in discussions to invest in API Holdings Pvt, which owns India’s largest online pharmacy chain Pharmeasy, according to people familiar with the matter.
API is seeking a valuation of at least $5.6 billion in a new funding round, said one of the people, who asked not to be identified as the information is private. SoftBank could invest $150 million to $200 million into the online pharmacy owner, the people said.